These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19636208)

  • 21. Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine.
    Plouffe BD; Kniazeva T; Mayer JE; Murthy SK; Sales VL
    FASEB J; 2009 Oct; 23(10):3309-14. PubMed ID: 19487310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial progenitor cells: current issues on characterization and challenging clinical applications.
    Resch T; Pircher A; Kähler CM; Pratschke J; Hilbe W
    Stem Cell Rev Rep; 2012 Sep; 8(3):926-39. PubMed ID: 22095429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
    Sen S; McDonald SP; Coates PT; Bonder CS
    Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy.
    Bianconi V; Sahebkar A; Kovanen P; Bagaglia F; Ricciuti B; Calabrò P; Patti G; Pirro M
    Pharmacol Ther; 2018 Jan; 181():156-168. PubMed ID: 28827151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cells and cardiovascular homeostasis: clinical implications.
    Pompilio G; Capogrossi MC; Pesce M; Alamanni F; DiCampli C; Achilli F; Germani A; Biglioli P
    Int J Cardiol; 2009 Jan; 131(2):156-67. PubMed ID: 18823669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
    Tousoulis D; Andreou I; Antoniades C; Tentolouris C; Stefanadis C
    Atherosclerosis; 2008 Dec; 201(2):236-47. PubMed ID: 18599065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?
    Werner N; Nickenig G
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):257-66. PubMed ID: 16322535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis.
    Hoenig MR; Bianchi C; Sellke FW
    Curr Drug Targets; 2008 May; 9(5):422-35. PubMed ID: 18473772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BM ageing: Implication for cell therapy with EPCs.
    Rurali E; Bassetti B; Perrucci GL; Zanobini M; Malafronte C; Achilli F; Gambini E
    Mech Ageing Dev; 2016 Oct; 159():4-13. PubMed ID: 27045606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells.
    Leone AM; Valgimigli M; Giannico MB; Zaccone V; Perfetti M; D'Amario D; Rebuzzi AG; Crea F
    Eur Heart J; 2009 Apr; 30(8):890-9. PubMed ID: 19299431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous endothelial progenitor cells transplantation for the therapy of primary pulmonary hypertension.
    Zeng C; Wang X; Hu X; Chen J; Wang L
    Med Hypotheses; 2007; 68(6):1292-5. PubMed ID: 17140742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concerns and hopes for stem cell therapy in cardiology: focus on endothelial progenitor cells.
    Ferrari R; Beltrami CA; Tavazzi L
    Cardiovasc Hematol Disord Drug Targets; 2010 Sep; 10(3):216-23. PubMed ID: 20929437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of endothelial progenitor cell function by micrornas.
    Goretti E; Wagner DR; Devaux Y
    Minerva Cardioangiol; 2013 Dec; 61(6):591-604. PubMed ID: 24253453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence].
    Sabatier F; Lacroix R; Camoin-Jau L; Anfosso F; Sampol J; Dignat-George F
    Rev Med Interne; 2011 Jan; 32(1):54-63. PubMed ID: 20541851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging biology of vascular wall progenitor cells in health and disease.
    Tilki D; Hohn HP; Ergün B; Rafii S; Ergün S
    Trends Mol Med; 2009 Nov; 15(11):501-9. PubMed ID: 19828379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progenitor cells in vascular disease.
    Roberts N; Jahangiri M; Xu Q
    J Cell Mol Med; 2005; 9(3):583-91. PubMed ID: 16202207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects.
    Rossi F; Bertone C; Montanile F; Miglietta F; Lubrano C; Gandini L; Santiemma V
    Microvasc Res; 2010 Sep; 80(2):274-9. PubMed ID: 20478316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endothelial progenitor cells and atherosclerosis].
    Hamed S; Roguin A
    Harefuah; 2006 May; 145(5):358-61, 397. PubMed ID: 16805218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of chemokines, cytokines and adhesion molecules in stem cell trafficking and homing.
    Cui Y; Madeddu P
    Curr Pharm Des; 2011 Oct; 17(30):3271-9. PubMed ID: 21919879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From bench to bedside: what physicians need to know about endothelial progenitor cells.
    Mayr M; Niederseer D; Niebauer J
    Am J Med; 2011 Jun; 124(6):489-97. PubMed ID: 21605723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.